PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
26-Apr-2022 Untargeted Lipidomics Now Available with Creative Proteomics’s New Cutting-Edge Lipidomics Platform Creative Proteomics
26-Apr-2022 Pronalyse Unveils Gene Therapy Products Characterization Service to Safely Accelerate Drug Development Creative Proteomics
26-Apr-2022 Creative Proteomics Metabolomics Expands Service Offering with the Launch of Plant Untargeted Metabolomics Service Creative Proteomics
26-Apr-2022 MicrobioSeq Division Releases Viral Metagenomics Services to Study Viruses CD Genomics
26-Apr-2022 MicrobioSeq Introduces Fungal Whole-Genome De Novo Sequencing Platform to Facilitate Microbial Research CD Genomics
26-Apr-2022 CD Genomics Releases Human Mitochondrial DNA Sequencing for Disease Research and Biodiversity Assessment CD Genomics
26-Apr-2022 Creative BioMart Microbe Provides One-Stop Service for Bacteriocin Production Creative BioMart Microbe
25-Apr-2022 MitoRx Therapeutics Announces Seed Financing to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases MitoRx
25-Apr-2022 Epitopea Announces $14 Million Financing to Advance Cancer Immunotherapeutics Epitopea
25-Apr-2022 Tower Cold Chain wins Queen’s Award for International Trade Tower Cold Chain
25-Apr-2022 Creative Enzymes to Exhibit at the PEGS Boston Summit on May 2-6, 2022 Creative Enzymes
25-Apr-2022 Biomunex appoints Dr. Simon Plyte, PhD, as Chief Scientific Officer to boost clinical and business development Andrew Lloyd Associates
22-Apr-2022 Scitara™ Digital Lab Exchange DLX™ gains ISO certification and advances the modern lab with the latest release of its barrier-breaking lab integration platform Scitara
21-Apr-2022 Evaluate announces global strategic collaboration with Treehill Partners Evaluate
21-Apr-2022 PacBio transforms access to the epigenome and streamlines workflows PacBio
21-Apr-2022 PacBio and Children’s Mercy Kansas City Expand Collaboration Taking a Multi-Omics Approach to Characterize Rare Disease PacBio
21-Apr-2022 Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Novavax
21-Apr-2022 EIB provides €15 million to fund coronavirus research at IRBM IRBM
20-Apr-2022 Samsung Biologics completes full acquisition of Samsung Bioepis Samsung Biologics
20-Apr-2022 Accelerating Peptide Drug Research with Creative Peptides’ Premade Peptide Library Creative Peptides